# Metformin Treatment for Colon Cancer

> **NCT03359681** · PHASE2 · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 48 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Metformin Hydrochloride
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03359681
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-10
- **Primary completion:** 2021-09-02
- **Final completion:** 2021-10-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359681, "Metformin Treatment for Colon Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03359681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*